Drug Prices, Trade Deal Hot For 1st Democratic Debate
This article was originally published in Scrip
Prescription drug prices and the Trans-Pacific Partnership (TPP) are sure bets to be among the hot cards played on Oct. 13 in Las Vegas at the first of six debates among the 2016 Democratic contenders, former secretary of State Hillary Clinton, Sen. Bernie Sanders (I-VT) and those three other guys – former Maryland governor Martin O'Malley and former US senators James Webb (VA) and Lincoln Chafee (RI).
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.